Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study.
about
Red cell and human leukocyte antigen alloimmunization in candidates for renal transplantation: a reality.Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.Frequencies and specificities of "enzyme-only" detected erythrocyte alloantibodies in patients hospitalized in austria: is an enzyme test required for routine red blood cell antibody screening?Analysis of case-cohort designs with binary outcomes: Improving efficiency using whole-cohort auxiliary information.Iron deficiency anemia in the emergency department: over-utilization of red blood cell transfusion and infrequent use of iron supplementation.Red cell alloimmunisation in patients with different types of infections.Immunosuppressants and alloimmunization against red blood cell transfusions.Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients.Age of platelet concentrates and time to the next transfusion.Allele and haplotype frequencies of HLA-A, B, C, DRB1 and DQB1 genes in polytransfused patients in ethnically diverse populations from Brazil.Effect of storage of red blood cells on alloimmunization.Observational etiologic research. Part 4--Matching in case-control studies: almost always a bad idea.Transfusion Medicine and Molecular Genetic Methods.
P2860
Q37057001-17040517-FB0D-4F2C-B63F-FCAC75853502Q37555796-1A056D89-B46E-4B82-BA7C-08DAE0A5332AQ37699918-01AF5A5C-AA76-420E-95C5-0977FAB47AADQ38263085-6756FD10-E107-47F0-8C88-9704BD431242Q39000612-FD9559CD-A28D-4007-803D-200F03C3CD34Q40092045-48F11464-CF41-4B5B-8C58-5E6BF82137A6Q43945814-F19D995B-7F4B-4CC5-B7A5-379CF2A88CB4Q47604819-A556CCD9-10E0-4C19-9D73-C0D182F57BE8Q48091096-B0069352-5461-43D3-B569-06D6169FF790Q50439205-8CFA6ADA-6A2C-4C4C-9BE4-9EC549D35C27Q50493920-D11F6F55-5FDF-42D5-B4CA-BEF66F57914BQ54777766-AB7E4C72-AE97-48E8-84A1-A72893BAC201Q55234148-19051AC6-9501-4B26-B829-6CC0C7493246
P2860
Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Risk Factors for Alloimmunisat ...... (R-FACT): a case cohort study.
@ast
Risk Factors for Alloimmunisat ...... (R-FACT): a case cohort study.
@en
type
label
Risk Factors for Alloimmunisat ...... (R-FACT): a case cohort study.
@ast
Risk Factors for Alloimmunisat ...... (R-FACT): a case cohort study.
@en
prefLabel
Risk Factors for Alloimmunisat ...... (R-FACT): a case cohort study.
@ast
Risk Factors for Alloimmunisat ...... (R-FACT): a case cohort study.
@en
P2093
P2860
P1433
P1476
Risk Factors for Alloimmunisat ...... (R-FACT): a case cohort study.
@en
P2093
J G van der Bom
Jaap Jan Zwaginga
Saurabh Zalpuri
P2860
P356
10.1136/BMJOPEN-2012-001150
P577
2012-05-04T00:00:00Z